Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Total 13F shares
-
15,589,448
-
Share change
-
-561,850
-
Total reported value
-
$4,135,825,810
-
Put/Call ratio
-
160%
-
Price per share
-
$265.38
-
Number of holders
-
522
-
Value change
-
-$145,086,739
-
Number of buys
-
259
-
Number of sells
-
204
Institutional Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q4 2016
As of 31 Dec 2016,
ISHARES TR - ISHARES BIOTECH (IBB) was held by
522 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,589,448 shares.
The largest 10 holders included
BANK OF AMERICA CORP /DE/, MORGAN STANLEY, CITIGROUP INC, GOLDMAN SACHS GROUP INC, UBS Group AG, JPMORGAN CHASE & CO, ROYAL BANK OF CANADA, ALLIANCEBERNSTEIN L.P., BNP PARIBAS ARBITRAGE, SA, and WELLS FARGO & COMPANY/MN.
This page lists
522
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.